Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-25-054293
Filing Date
2025-04-15
Accepted
2025-04-15 16:38:54
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 kytx_424b5_prospectus.htm 424B5 210504
2 GRAPHIC img65683277_0.jpg GRAPHIC 55411
3 GRAPHIC img65683277_1.jpg GRAPHIC 139443
4 GRAPHIC img65683277_2.jpg GRAPHIC 55411
  Complete submission text file 0000950170-25-054293.txt   556670
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Filer) CIK: 0001994702 (see all company filings)

EIN.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-286180 | Film No.: 25840080
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)